<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" VersionID="2" Owner="NLM" IndexingMethod="Curated"><PMID Version="2">37013484</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1528-3658</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>03</Day></PubDate></JournalIssue><Title>Molecular medicine (Cambridge, Mass.)</Title><ISOAbbreviation>Mol Med</ISOAbbreviation></Journal><ArticleTitle>m<sup>6</sup>A methyltransferase METTL3 programs CD4<sup>+</sup> T-cell activation and effector T-cell differentiation in systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>46</StartPage><MedlinePgn>46</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">46</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s10020-023-00643-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">Systemic lupus erythematosus (SLE) is an autoimmune disorder in which excessive CD4<sup>+</sup> T-cell activation and imbalanced effector T-cell differentiation play critical roles. Recent studies have implied a potential association between posttranscriptional N6-methyladenosine (m<sup>6</sup>A) modification and CD4<sup>+</sup> T-cell-mediated humoral immunity. However, how this biological process contributes to lupus is not well understood. In this work, we investigated the role of the m<sup>6</sup>A methyltransferase&#xa0;like 3 (METTL3) in CD4<sup>+</sup> T-cell activation, differentiation, and SLE pathogenesis both in vitro and in vivo.</AbstractText><AbstractText Label="METHODS">The expression of METTL3 was knocked down and METTL3 enzyme activity was inhibited using siRNA and catalytic inhibitor, respectively. In vivo evaluation of METTL3 inhibition on CD4<sup>+</sup> T-cell activation, effector T-cell differentiation, and SLE pathogenesis was achieved using a sheep red blood cell (SRBC)-immunized mouse model and a chronic graft versus host disease (cGVHD) mouse model. RNA-seq was performed to identify pathways and gene signatures targeted by METTL3. m<sup>6</sup>A RNA-immunoprecipitation qPCR was applied to confirm the m<sup>6</sup>A modification of METTL3 targets.</AbstractText><AbstractText Label="RESULTS">METTL3 was defective in the CD4<sup>+</sup> T cells of SLE patients. METTL3 expression varied following CD4<sup>+</sup> T-cell activation and effector T-cell differentiation in vitro. Pharmacological inhibition of METTL3 promoted the activation of CD4<sup>+</sup> T cells and influenced the differentiation of effector T cells, predominantly Treg cells, in vivo. Moreover, METTL3 inhibition increased antibody production and aggravated the lupus-like phenotype in cGVHD mice. Further investigation revealed that catalytic inhibition of METTL3 reduced Foxp3 expression by enhancing Foxp3 mRNA decay in a m<sup>6</sup>A-dependent manner, hence suppressing Treg cell differentiation.</AbstractText><AbstractText Label="CONCLUSION">In summary, our findings demonstrated that METTL3 was required for stabilizing Foxp3 mRNA via m<sup>6</sup>A modification to maintain the Treg differentiation program. METTL3 inhibition contributed to the pathogenesis of SLE by participating in the activation of CD4<sup>+</sup> T cells and imbalance of effector T-cell differentiation, which could serve as a potential target for therapeutic intervention in SLE.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Shuang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, 410011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Xingyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, 410011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Huan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, 410011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Zhi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, 410011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Meiling</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, 410011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jiali</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, 410011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Cheng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, 410011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Shuang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, 410011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Delong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, 410011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Sujie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, 410013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Hongjun</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Xiangya Hospital, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Ming</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1320-1093</Identifier><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, 410011, China. zhaoming307@csu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, 210042, China. zhaoming307@csu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>82030097</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Med</MedlineTA><NlmUniqueID>9501023</NlmUniqueID><ISSNLinking>1076-1551</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051858">Forkhead Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.1.1.-</RegistryNumber><NameOfSubstance UI="D008780">Methyltransferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.1.1.-</RegistryNumber><NameOfSubstance UI="C000596366">Mettl3 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051858" MajorTopicYN="N">Forkhead Transcription Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008780" MajorTopicYN="Y">Methyltransferases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050378" MajorTopicYN="Y">T-Lymphocytes, Regulatory</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autoimmune disorders</Keyword><Keyword MajorTopicYN="N">METTL3</Keyword><Keyword MajorTopicYN="N">N6-Methyladenosine</Keyword><Keyword MajorTopicYN="N">SLE</Keyword><Keyword MajorTopicYN="N">mRNA methylation</Keyword></KeywordList><CoiStatement>The authors have no relevant financial or non-financial interests to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>4</Day><Hour>3</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37013484</ArticleId><ArticleId IdType="pmc">PMC10068720</ArticleId><ArticleId IdType="doi">10.1186/s10020-023-00643-4</ArticleId><ArticleId IdType="pii">10.1186/s10020-023-00643-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carter EE, Barr SG, Clarke AE. The global burden of SLE: prevalence, health disparities and socioeconomic impact. Nat Rev Rheumatol. 2016;12:605&#x2013;620. doi: 10.1038/nrrheum.2016.137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2016.137</ArticleId><ArticleId IdType="pubmed">27558659</ArticleId></ArticleIdList></Reference><Reference><Citation>Choe J, et al. mRNA circularization by METTL3-eIF3h enhances translation and promotes oncogenesis. Nature. 2018;561:556&#x2013;560. doi: 10.1038/s41586-018-0538-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0538-8</ArticleId><ArticleId IdType="pmc">PMC6234840</ArticleId><ArticleId IdType="pubmed">30232453</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang EV, et al. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell. 2011;146:772&#x2013;784. doi: 10.1016/j.cell.2011.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.07.033</ArticleId><ArticleId IdType="pmc">PMC3387678</ArticleId><ArticleId IdType="pubmed">21871655</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgoffe GM, et al. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity. 2009;30:832&#x2013;844. doi: 10.1016/j.immuni.2009.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2009.04.014</ArticleId><ArticleId IdType="pmc">PMC2768135</ArticleId><ArticleId IdType="pubmed">19538929</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez-Villar M, Hafler DA. Regulatory T cells in autoimmune disease. Nat Immunol. 2018;19:665&#x2013;673. doi: 10.1038/s41590-018-0120-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-018-0120-4</ArticleId><ArticleId IdType="pmc">PMC7882196</ArticleId><ArticleId IdType="pubmed">29925983</ArticleId></ArticleIdList></Reference><Reference><Citation>Essig K, et al. Roquin suppresses the PI3K-mTOR signaling pathway to inhibit T helper cell differentiation and conversion of Treg to Tfr cells. Immunity. 2017;47:1067&#x2013;1082.e12. doi: 10.1016/j.immuni.2017.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.11.008</ArticleId><ArticleId IdType="pubmed">29246441</ArticleId></ArticleIdList></Reference><Reference><Citation>Gleichmann E, Van Elven EH, Van der Veen JP. A systemic lupus ery thematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation. Preferential formation of autoantibodies characteristic of SLE. Eur J Immunol. 1982;12(2):152&#x2013;159. doi: 10.1002/eji.1830120210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.1830120210</ArticleId><ArticleId IdType="pubmed">6978818</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, et al. OX40L induces helper T cell differentiation during cell immunity of asthma through PI3K/AKT and P38 MAPK signaling pathway. J Transl Med. 2018;16:74. doi: 10.1186/s12967-018-1436-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1436-4</ArticleId><ArticleId IdType="pmc">PMC5859438</ArticleId><ArticleId IdType="pubmed">29554934</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H, Long L, Zhou P, Chapman NM, Chi H. mTOR signaling at the crossroads of environmental signals and T-cell fate decisions. Immunol Rev. 2020;295:15&#x2013;38. doi: 10.1111/imr.12845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12845</ArticleId><ArticleId IdType="pmc">PMC8101438</ArticleId><ArticleId IdType="pubmed">32212344</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishihara S, et al. Rap1 prevents colitogenic Th17 cell expansion and facilitates Treg cell differentiation and distal TCR signaling. Commun Biol. 2022;5:206. doi: 10.1038/s42003-022-03129-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-022-03129-x</ArticleId><ArticleId IdType="pmc">PMC8897436</ArticleId><ArticleId IdType="pubmed">35246619</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitoh A, et al. Indispensable role of the Runx1-Cbfbeta transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells. Immunity. 2009;31:609&#x2013;620. doi: 10.1016/j.immuni.2009.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2009.09.003</ArticleId><ArticleId IdType="pubmed">19800266</ArticleId></ArticleIdList></Reference><Reference><Citation>Li HB, et al. m(6)A mRNA methylation controls T cell homeostasis by targeting the IL-7/STAT5/SOCS pathways. Nature. 2017;548:338&#x2013;342. doi: 10.1038/nature23450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature23450</ArticleId><ArticleId IdType="pmc">PMC5729908</ArticleId><ArticleId IdType="pubmed">28792938</ArticleId></ArticleIdList></Reference><Reference><Citation>Li XC, Jin F, Wang BY, Yin XJ, Hong W, Tian FJ. The m6A demethylase ALKBH5 controls trophoblast invasion at the maternal-fetal interface by regulating the stability of CYR61 mRNA. Theranostics. 2019;9(13):3853&#x2013;3865. doi: 10.7150/thno.31868.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.31868</ArticleId><ArticleId IdType="pmc">PMC6587351</ArticleId><ArticleId IdType="pubmed">31281518</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N, et al. METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection. Cell Rep. 2021;35:109091. doi: 10.1016/j.celrep.2021.109091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109091</ArticleId><ArticleId IdType="pmc">PMC8090989</ArticleId><ArticleId IdType="pubmed">33961823</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Boulougoura A, Endo Y, Tsokos GC. Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies. J Autoimmun. 2022;132:102870. doi: 10.1016/j.jaut.2022.102870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2022.102870</ArticleId><ArticleId IdType="pubmed">35872102</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, et al. A METTL3&#x2013;METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2014;10:93&#x2013;95. doi: 10.1038/nchembio.1432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.1432</ArticleId><ArticleId IdType="pmc">PMC3911877</ArticleId><ArticleId IdType="pubmed">24316715</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Q, et al. The study of METTL14, ALKBH5, and YTHDF2 in peripheral blood mononuclear cells from systemic lupus erythematosus. Mol Genet Genom Med. 2020;8:e1298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7507441</ArticleId><ArticleId IdType="pubmed">32583611</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Q, et al. Decreased peripheral blood ALKBH5 correlates with markers of autoimmune response in systemic lupus erythematosus. Dis Mark. 2020 doi: 10.1155/2020/8193895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/8193895</ArticleId><ArticleId IdType="pmc">PMC7334764</ArticleId><ArticleId IdType="pubmed">32685056</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak A, Kow NY. The pathology of T cells in systemic lupus erythematosus. J Immunol Res. 2014 doi: 10.1155/2014/419029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/419029</ArticleId><ArticleId IdType="pmc">PMC4017881</ArticleId><ArticleId IdType="pubmed">24864268</ArticleId></ArticleIdList></Reference><Reference><Citation>Mijnheer G, et al. Conserved human effector Treg cell transcriptomic and epigenetic signature in arthritic joint inflammation. Nat Commun. 2021;12:2710. doi: 10.1038/s41467-021-22975-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22975-7</ArticleId><ArticleId IdType="pmc">PMC8113485</ArticleId><ArticleId IdType="pubmed">33976194</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulton VR, Tsokos GC. T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity. J Clin Invest. 2015;125:2220&#x2013;2227. doi: 10.1172/JCI78087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI78087</ArticleId><ArticleId IdType="pmc">PMC4497749</ArticleId><ArticleId IdType="pubmed">25961450</ArticleId></ArticleIdList></Reference><Reference><Citation>Ping XL, et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 2014;24:177&#x2013;189. doi: 10.1038/cr.2014.3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2014.3</ArticleId><ArticleId IdType="pmc">PMC3915904</ArticleId><ArticleId IdType="pubmed">24407421</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakaguchi S, et al. Regulatory T cells and human disease. Annu Rev Immunol. 2020;38:541&#x2013;566. doi: 10.1146/annurev-immunol-042718-041717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-042718-041717</ArticleId><ArticleId IdType="pubmed">32017635</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi LZ, et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med. 2011;208:1367&#x2013;1376. doi: 10.1084/jem.20110278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20110278</ArticleId><ArticleId IdType="pmc">PMC3135370</ArticleId><ArticleId IdType="pubmed">21708926</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi H, Wei J, He C. Where, when, and how: context-dependent functions of RNA methylation writers, readers, and erasers. Mol Cell. 2019;74:640&#x2013;650. doi: 10.1016/j.molcel.2019.04.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.04.025</ArticleId><ArticleId IdType="pmc">PMC6527355</ArticleId><ArticleId IdType="pubmed">31100245</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J, et al. METTL3 promotes the resistance of glioma to temozolomide via increasing MGMT and ANPG in a m(6)A dependent manner. Front Oncol. 2021;11:702983. doi: 10.3389/fonc.2021.702983.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2021.702983</ArticleId><ArticleId IdType="pmc">PMC8320395</ArticleId><ArticleId IdType="pubmed">34336690</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong J, et al. m(6)A mRNA methylation sustains Treg suppressive functions. Cell Res. 2018;28:253&#x2013;256. doi: 10.1038/cr.2018.7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2018.7</ArticleId><ArticleId IdType="pmc">PMC5799823</ArticleId><ArticleId IdType="pubmed">29303144</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P, Doxtader KA, Nam Y. structural basis for cooperative function of Mettl3 and Mettl14 methyltransferases. Mol Cell. 2016;63:306&#x2013;317. doi: 10.1016/j.molcel.2016.05.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.05.041</ArticleId><ArticleId IdType="pmc">PMC4958592</ArticleId><ArticleId IdType="pubmed">27373337</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, et al. Mettl3-mediated mRNA m(6)A methylation promotes dendritic cell activation. Nat Commun. 2019;10:1898. doi: 10.1038/s41467-019-09903-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09903-6</ArticleId><ArticleId IdType="pmc">PMC6478715</ArticleId><ArticleId IdType="pubmed">31015515</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei J, Liu F, Lu Z, Fei Q, Ai Y, He PC, et al. Differential m(6)A, m(6)A(m), and m(1)A demethylation mediated by FTO in the cell nucleus and cytoplasm. Mol Cell. 2018;71(6):973&#x2013;85.e5. doi: 10.1016/j.molcel.2018.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.08.011</ArticleId><ArticleId IdType="pmc">PMC6151148</ArticleId><ArticleId IdType="pubmed">30197295</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler R, et al. m(6)A modification controls the innate immune response to infection by targeting type I interferons. Nat Immunol. 2019;20:173&#x2013;182. doi: 10.1038/s41590-018-0275-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-018-0275-z</ArticleId><ArticleId IdType="pubmed">30559377</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu R, et al. MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation. J Clin Invest. 2018;128:2551&#x2013;2568. doi: 10.1172/JCI97426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI97426</ArticleId><ArticleId IdType="pmc">PMC5983326</ArticleId><ArticleId IdType="pubmed">29757188</ArticleId></ArticleIdList></Reference><Reference><Citation>Yankova E, et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature. 2021;593:597&#x2013;601. doi: 10.1038/s41586-021-03536-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03536-w</ArticleId><ArticleId IdType="pmc">PMC7613134</ArticleId><ArticleId IdType="pubmed">33902106</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Y, et al. METTL3-dependent m(6)A modification programs T follicular helper cell differentiation. Nat Commun. 2021;12:1333. doi: 10.1038/s41467-021-21594-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21594-6</ArticleId><ArticleId IdType="pmc">PMC7910450</ArticleId><ArticleId IdType="pubmed">33637761</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaccara S, Ries RJ, Jaffrey SR. Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol. 2019;20:608&#x2013;624. doi: 10.1038/s41580-019-0168-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-019-0168-5</ArticleId><ArticleId IdType="pubmed">31520073</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, Yang Y, Sun BF, Shi Y, Yang X, Xiao W, et al. FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis. Cell Res. 2014;24(12):1403&#x2013;1419. doi: 10.1038/cr.2014.151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2014.151</ArticleId><ArticleId IdType="pmc">PMC4260349</ArticleId><ArticleId IdType="pubmed">25412662</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng G, Dahl JA, Niu Y, Fedorcsak P, Huang CM, Li CJ, et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell. 2013;49(1):18&#x2013;29. doi: 10.1016/j.molcel.2012.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2012.10.015</ArticleId><ArticleId IdType="pmc">PMC3646334</ArticleId><ArticleId IdType="pubmed">23177736</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Zeng P, Li YH, Zhang Z, Cui Q. SRAMP: prediction of mammalian N6-methyladenosine (m6A) sites based on sequence-derived features. Nucleic Acids Res. 2016;44:e91. doi: 10.1093/nar/gkw104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw104</ArticleId><ArticleId IdType="pmc">PMC4889921</ArticleId><ArticleId IdType="pubmed">26896799</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Zhang X, Hu J, Qu R, Yu Z, Xu H, et al. m(6)A demethylase ALKBH5 controls CD4(+) T cell pathogenicity and promotes autoimmunity. Sci Adv. 2021;7(25):eabg0470. doi: 10.1126/sciadv.abg0470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abg0470</ArticleId><ArticleId IdType="pmc">PMC8208713</ArticleId><ArticleId IdType="pubmed">34134995</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>